BE assessment regarding first time point Cmax [Study As­sess­ment]

posted by Mann – India, 2018-12-10 00:28  – Posting: # 19673
Views: 3,367

Dear Ohlbe,

Thank you for your detailed clarification.

Could you please share your views and suggestions from US-FDA and ICH perspective?

Best regards,
Mann

Complete thread:

Activity
 Admin contact
20,255 posts in 4,263 threads, 1,398 registered users;
online 13 (0 registered, 13 guests [including 7 identified bots]).
Forum time (Europe/Vienna): 09:01 CET

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5